Szulczyńska-Gabor J, Fuksiewicz W, Emerele A, Głośnicka M, Bowszyc-Dmochowska M, Żaba R. CASE REPORTSHidradenitis suppurativa – the therapeutic possibilities – case report. Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii. 2008;25(3):142-142.
APA
Szulczyńska-Gabor, J., Fuksiewicz, W., Emerele, A., Głośnicka, M., Bowszyc-Dmochowska, M., & Żaba, R. (2008). CASE REPORTSHidradenitis suppurativa – the therapeutic possibilities – case report. Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii, 25(3), 142-142.
Chicago
Szulczyńska-Gabor, Joanna, Wiesława Fuksiewicz, Atena Emerele, Marzena Głośnicka, Monika Bowszyc-Dmochowska, and Ryszard Żaba. 2008. "CASE REPORTSHidradenitis suppurativa – the therapeutic possibilities – case report". Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii 25 (3): 142-142.
Harvard
Szulczyńska-Gabor, J., Fuksiewicz, W., Emerele, A., Głośnicka, M., Bowszyc-Dmochowska, M., and Żaba, R. (2008). CASE REPORTSHidradenitis suppurativa – the therapeutic possibilities – case report. Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii, 25(3), pp.142-142.
MLA
Szulczyńska-Gabor, Joanna et al. "CASE REPORTSHidradenitis suppurativa – the therapeutic possibilities – case report." Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii, vol. 25, no. 3, 2008, pp. 142-142.
Vancouver
Szulczyńska-Gabor J, Fuksiewicz W, Emerele A, Głośnicka M, Bowszyc-Dmochowska M, Żaba R. CASE REPORTSHidradenitis suppurativa – the therapeutic possibilities – case report. Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii. 2008;25(3):142-142.
Hidradenitis suppurativa is a severe skin condition of unknown aetiology and chronic, long standing course, in which skin lesions are characterized by nodules and inflammatory tumours, which usually disappear leaving subsequent scarring. It still causes huge therapeutic difficulties, despite quite frequent occurrence. We present the case of a 47-year-old male patient with rapid progression, serious course and therapy resistance. In this article we discuss new therapeutic options, especially biological therapies. Recently we place our hopes in biological treatment.
